Interleukin-22 Inhibits Bleomycin-Induced Pulmonary Fibrosis
Open Access
- 1 January 2013
- journal article
- research article
- Published by Wiley in Mediators of Inflammation
- Vol. 2013, 1-11
Abstract
Pulmonary fibrosis is a progressive and fatal fibrotic disease of the lungs with unclear etiology. Recent insight has suggested that early injury/inflammation of alveolar epithelial cells could lead to dysregulation of tissue repair driven by multiple cytokines. Although dysregulation of interleukin- (IL-) 22 is involved in various pulmonary pathophysiological processes, the role of IL-22 in fibrotic lung diseases is still unclear and needs to be further addressed. Here we investigated the effect of IL-22 on alveolar epithelial cells in the bleomycin- (BLM-) induced pulmonary fibrosis. BLM-treated mice showed significantly decreased level of IL-22 in the lung. IL-22 producedγδT cells were also decreased significantly both in the tissues of lungs and spleens. Administration of recombinant human IL-22 to alveolar epithelial cell line A549 cells ameliorated epithelial to mesenchymal transition (EMT) and partially reversed the impaired cell viability induced by BLM. Furthermore, blockage of IL-22 deteriorated pulmonary fibrosis, with elevated EMT marker (α-smooth muscle actin (α-SMA)) and overactivated Smad2. Our results indicate that IL-22 may play a protective role in the development of BLM-induced pulmonary fibrosis and may suggest IL-22 as a novel immunotherapy tool in treating pulmonary fibrosis.Keywords
Funding Information
- National Natural Science Foundation of China (81072463, 211Med-XZZD03)
- Fudan University (81072463, 211Med-XZZD03)
This publication has 33 references indexed in Scilit:
- Human fetal lymphoid tissue–inducer cells are interleukin 17–producing precursors to RORC+ CD127+ natural killer–like cellsNature Immunology, 2008
- A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responsesNature Immunology, 2008
- The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγtNature Immunology, 2008
- Maturing dendritic cells are an important source of IL-29 and IL-20 that may cooperatively increase the innate immunity of keratinocytesJournal of Leukocyte Biology, 2008
- Molecular Targets in Pulmonary FibrosisChest, 2007
- Interleukin-22, a TH17 cytokine, mediates IL-23-induced dermal inflammation and acanthosisNature, 2006
- Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrixProceedings of the National Academy of Sciences, 2006
- Interleukin-22American Journal of Respiratory Cell and Molecular Biology, 2004
- IL-22 Increases the Innate Immunity of TissuesImmunity, 2004
- Interleukin-22 (IL-22) Activates the JAK/STAT, ERK, JNK, and p38 MAP Kinase Pathways in a Rat Hepatoma Cell LineJournal of Biological Chemistry, 2002